Stevens succeeds Milton Boyer, who has stepped down as CEO but will remain closely involved with the business as an independent member of Kindeva’s Board of Directors
DNA nanorobots—tiny, self-assembling machines capable of detecting diseases in blood samples within 2–4 hours
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
Future of manufacturing lies in mobility based manufacturing
Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Sapala Organics
Sales from Novo’s GLP-1 portfolio—including Wegovy for obesity and Ozempic for type 2 diabetes reached $5.6 billion
In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base
Stephan brings more than 20 years of leadership experience in the pharmaceutical industry
Miels will formally assume the role on January 1, 2026
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Subscribe To Our Newsletter & Stay Updated
